Artemis Medicare Services Ltd vs Aspira Pathlab Diagnostics Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 23, 2026

Key Highlights

The Latest Trading Price of Artemis Medicare Services Ltd is ₹ 286.1 as of 23 Oct 15:30 . The P/E Ratio of Artemis Medicare Services Ltd changed from 46.9 on March 2024 to 31.3 on March 2026 . This represents a CAGR of -6.52% over 6 yearsThe P/E Ratio of Aspira Pathlab & Diagnostics Ltd changed from 43.3 on March 2025 to 0 on March 2026 . This represents a CAGR of -100.00% over 5 years The Market Cap of Artemis Medicare Services Ltd changed from ₹ 2306 crore on March 2024 to ₹ 3249 crore on March 2026 . This represents a CAGR of 5.87% over 6 yearsThe Market Cap of Aspira Pathlab & Diagnostics Ltd changed from ₹ 31.91 crore on March 2024 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Artemis Medicare Services Ltd for the Jun '26 is ₹ 292.7 crore as compare to the Mar '26 revenue of ₹ 287.01 crore. This represent the growth of 1.98% The revenue of Aspira Pathlab & Diagnostics Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Artemis Medicare Services Ltd for the Jun '26 is ₹ 61.82 crore as compare to the Mar '26 ebitda of ₹ 59.38 crore. This represent the growth of 4.11% The ebitda of Aspira Pathlab & Diagnostics Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Artemis Medicare Services Ltd changed from ₹ 16.52 crore to ₹ 31.44 crore over 9 quarters. This represents a CAGR of 33.11% The net profit of Aspira Pathlab & Diagnostics Ltd changed from ₹ 0.05 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The Dividend Payout of Artemis Medicare Services Ltd changed from 15.2 % on March 2023 to 6.89 % on March 2026 . This represents a CAGR of -17.95% over 4 yearsThe Dividend Payout of Aspira Pathlab & Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Artemis Medicare Services Ltd

Artemis Medicare Services Limited was incorporated on May 18, 2004.
It commenced the commercial operation by setting up Artemis Hospital (formerly Artemis Health Institute) at Gurugram on July 16, 2007.
The Company is the holding Company of Artemis Cardiac Care Private Limited and a Subsidiary of Constructive Finance Private Limited.
At present, the Company is engaged in managing and operating of multi specialty hospitals.
Artemis Hospital (a unit of Artemis Medicare Services Limited) is spread across 9 acres, is a 395 bed; state-of-the-art multispeciality hospital located in Gurugram, India. Artemis Health Institute is a healthcare venture launched by the Promoters of the Apollo Tyres Group.

About Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab & Diagnostics Limited (ASDL) was incorporated in July, 1973.
ASDL is a leading pathology specialist, with Pan-India presence.
It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses.
The Company, with a wider presence in Maharashtra India, enjoys a loyal customer base, that reflects on its strength as a brand, providing superior diagnostic testing and services. Presently, Company is engaged into the business of running, owning, managing and administering Diagnostics Centers.
Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai. ASDL ideology is founded on technological supremacy, patient centric approach, and dependable diagnostic results.

FAQs for the comparison of Artemis Medicare Services Ltd and Aspira Pathlab & Diagnostics Ltd

Which company has a larger market capitalization, Artemis Medicare Services Ltd or Aspira Pathlab & Diagnostics Ltd?

Market cap of Artemis Medicare Services Ltd is 4,529 Cr while Market cap of Aspira Pathlab & Diagnostics Ltd is 129 Cr

What are the key factors driving the stock performance of Artemis Medicare Services Ltd and Aspira Pathlab & Diagnostics Ltd?

The stock performance of Artemis Medicare Services Ltd and Aspira Pathlab & Diagnostics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Artemis Medicare Services Ltd and Aspira Pathlab & Diagnostics Ltd?

As of October 23, 2026, the Artemis Medicare Services Ltd stock price is INR ₹286.1. On the other hand, Aspira Pathlab & Diagnostics Ltd stock price is INR ₹126.05.

How do dividend payouts of Artemis Medicare Services Ltd and Aspira Pathlab & Diagnostics Ltd compare?

To compare the dividend payouts of Artemis Medicare Services Ltd and Aspira Pathlab & Diagnostics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.